文献速递血液净化与透析

老年血液透析患者血管通路类型与临床结局

Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-08-10

本研究纳入9458例≥67岁、以中心静脉导管起始血液透析且6个月内放置动静脉瘘(7433例)或移植血管(2025例)的美国患者,采用倾向性评分匹配分析。结果显示,尽管动静脉瘘组导管依赖时间更长,但感染相关住院和菌血症/败血症相关住院风险更低,死亡风险也更低。

要点

  • 老年患者以导管起始透析后6个月内行动静脉瘘,感染相关住院风险低于移植血管。
  • 动静脉瘘组导管依赖时间更长,但死亡风险仍低于移植血管组。
  • 选择永久通路类型时,不能仅因导管依赖时间长而否定动静脉瘘。

核心结论

  • 老年患者以中心静脉导管起始透析后6个月内行动静脉瘘,感染相关住院和死亡风险低于移植血管。

研究设计与样本

  • 回顾性观察性研究,纳入9458例≥67岁美国患者,2010年7月1日至2011年6月30日以中心静脉导管起始透析且无其他血管通路,6个月内接受动静脉瘘(n=7433)或移植血管(n=2025)。
  • 采用倾向性评分匹配分析评估患者生存。

主要发现

  • 动静脉瘘组在通路放置后6个月内各月中心静脉导管依赖比例均高于移植血管组(P<0.001)。
  • 动静脉瘘组全因感染相关住院调整相对风险为0.93(95%CI 0.87-0.99;P=0.01),低于移植血管组。
  • 动静脉瘘组菌血症/败血症相关住院调整相对风险为0.90(95%CI 0.82-0.98;P=0.02),低于移植血管组。
  • 动静脉瘘组调整死亡风险比0.76(95%CI 0.73-0.80;P<0.001),低于移植血管组。

临床怎么用

  • 老年患者以导管起始透析后,若6个月内可行动静脉瘘,应优先考虑动静脉瘘而非移植血管。
  • 即使预计导管依赖时间较长,动静脉瘘仍可能带来感染和生存获益。

局限性

  • 观察性设计可能存在残余混杂。
  • 仅纳入美国≥67岁患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The optimal type of initial permanent access for hemodialysis among the elderly is controversial. Duration of central venous catheter dependence, patient comorbidities, and life expectancy are important considerations in whether to place an arteriovenous fistula or graft. We used an observational study design to compare clinical outcomes in elderly patients who initiated hemodialysis with a central venous catheter and subsequently had an arteriovenous fistula or graft placed. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified 9458 United States patients ages ≥67 years old who initiated hemodialysis from July 1, 2010 to June 30, 2011 with a central venous catheter and no secondary vascular access and then received an arteriovenous fistula (n=7433) or graft (n=2025) within 6 months. We evaluated key clinical outcomes during the 6 months after vascular access placement coincident with high rates of catheter use and used a matched propensity score analysis to examine patient survival. RESULTS: Central venous catheter dependence was greater in every month during the 6-month period after arteriovenous fistula versus graft placement (P<0.001). However, rates of all-cause infection-related hospitalization (adjusted relative risk, 0.93; 95% confidence interval, 0.87 to 0.99; P=0.01) and bacteremia/septicemia-related hospitalization (adjusted relative risk, 0.90; 95% confidence interval, 0.82 to 0.98; P=0.02) were lower in the arteriovenous fistula versus graft group as was the adjusted risk of death (hazard ratio, 0.76; 95% confidence interval, 0.73 to 0.80; P<0.001). CONCLUSIONS: Despite extended central venous catheter dependence, elderly patients initiating hemodialysis with a central venous catheter who underwent arteriovenous fistula placement within 6 months had fewer hospitalizations due to infections and a lower likelihood of death than those receiving an arteriovenous graft.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lee T, Thamer M, Zhang Q, et al. Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017. PMID: 28798220. doi:10.2215/CJN.01410217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。